The Emerging Government Requirement for Economic Evaluation of Pharmaceuticals
- 1 January 1994
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 6 (1), 42-50
- https://doi.org/10.2165/00019053-199400061-00012
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Guidelines for Economic Analysis of Pharmaceutical ProductsPharmacoEconomics, 1993
- Technology assessment and cost-effectiveness analysis: misguided guidelines?1993
- Tentative guidelines for using clinical and economic evaluations revisited.1993
- Assessment of Costs and Benefits of Drug Therapy for Treatment-Resistant Schizophrenia in the United KingdomThe British Journal of Psychiatry, 1993
- The Australian Guidelines for subsidisation of pharmaceuticals: the road to cost-effective drug prescribing?1992
- Cost‐effectiveness guidelines for reimbursement of pharmaceuticals: Is economic evaluation ready for its enhanced status?Health Economics, 1992
- How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1992
- Australian Guidelines for Cost-Effectiveness Studies of PharmaceuticalsPharmacoEconomics, 1992
- Farewell to promoting goodbuys?The Lancet, 1991
- Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical CompaniesNew England Journal of Medicine, 1991